CN101129425A - Traditional Chinese medicine for treating zoster - Google Patents
Traditional Chinese medicine for treating zoster Download PDFInfo
- Publication number
- CN101129425A CN101129425A CNA2007100713812A CN200710071381A CN101129425A CN 101129425 A CN101129425 A CN 101129425A CN A2007100713812 A CNA2007100713812 A CN A2007100713812A CN 200710071381 A CN200710071381 A CN 200710071381A CN 101129425 A CN101129425 A CN 101129425A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- oral administration
- group
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
Disclosed is Chinese medicament for treating herpes zoster, which can be prepared into dose forms of externally-applying group and oral administration group, the externally-applying group comprises the raw materials of (by weight portions): depositum urinae hominis 25-35 parts, carbonized hair 25-35 parts, cotton rose hibiscus leaf 52-68 parts, and right amount of sesame oil. The oral administration group comprises the raw materials of (by weight portions): flavescent sophora root 25-35 parts, coix seed 25-35 parts, poria cocos wolf 16-24 parts, root of Dahurain angelica 8-12 parts, rhubarb horsetails 4-6 parts, honey-suckle stem 25-35 parts, red peony root 8-12 parts, aristolochia stem 8-12 parts, Chinese angelica root 8-12 parts, buthus martensi kirsch 8-12 parts, black-tail snake 8-12 parts, bupleurum root 8-12 parts and processed nutgrass flatsedge rhizome 8-12 parts.
Description
Technical field
The present invention relates to the dermopathic medicine of a kind of treatment, specifically is the Chinese medicine of treatment herpes zoster.
Background technology
Herpes zoster (herpes zoster) is the easiest popular acute inflammation dermatoses that is caused by varicella zoster virus in spring, and the traditional Chinese medical science is called " skirt-roof HUOLONG ", " herpes zoster ", is commonly called as " herpes zoster ".Its main feature is for bunch catchmenting bubble, along the zonal distribution of trooping of side peripheral nerve do, with obvious neuralgia.Primary infection shows as chickenpox, and virus can be hidden for a long time at the spinal cord posterior root ganglion later on, and immunologic function weakens can bring out varicella zoster virus activity once again, and growth and breeding involves skin along peripheral nerve, and herpes zoster takes place.
Herpes zoster can betide each different parts of whole body, with occur between waist, between costa sternales and back is for seeing more; Having an intense pain often appears in the patient, the influence sleep; If treat untimelyly, after skin lesion disappears, still leave over pain, the several months can not disappear fully.If herpes zoster appears at head, face, also easily because of invading neural headache, the facial paralysis that occurs of women's head-ornaments portion.If the eyes cornea is invaded, even also can cause losing one's sight.Older, Low and suffer from chronic disease person such as tumor, the state of an illness can be even more serious.
At present, though for the existing several different methods of treatment herpes zoster, but it is slower all to take effect, and curative effect is not too remarkable; Thereby for the patient, that bears is painful more, and the expense of treatment is bigger.
Summary of the invention
The purpose of this invention is to provide a kind of improvement for the treatment of the Chinese medicine of herpes zoster, this medicine should be able to overcome the deficiency of above-mentioned background technology, cures herpes zoster effectively, and has instant effect, effective percentage height, the characteristics that medical expense is lower.
The technical solution used in the present invention is: a kind of Chinese medicine for the treatment of herpes zoster comprises external application group and group for oral administration;
Raw material in the external application group is formed and weight portion is: calamitas urinae hominis 25-35 part, and Crinis Carbonisatus 25-35 part, Folium Hibisci Mutabilis 52-68 part, Oleum sesami is an amount of;
Raw material in the group for oral administration forms and weight portion is: Radix Sophorae Flavescentis 25-35 part, Semen Coicis 25-35 part, Poria 16-24 part, Radix Angelicae Dahuricae 8-12 part, Radix Et Rhizoma Rhei 4-6, Caulis Lonicerae 25-35 part, Radix Paeoniae Rubra 8-12 part, Caulis Akebiae 8-12 part, Radix Angelicae Sinensis 8-12 part, Scorpio 8-12 part, Zaocys 8-12 part, Radix Bupleuri 8-12 part, Rhizoma Cyperi (processed) 8-12 part.
Raw material in the described external application group is formed and weight portion is: 30 parts of calamitas urinae hominises, and 30 parts of Crinis Carbonisatus, 60 parts of Folium Hibisci Mutabiliss, Oleum sesami is an amount of;
Raw material in described for oral administration group is formed and weight portion is: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Semen Coiciss, 20 parts in Poria, 10 parts of the Radixs Angelicae Dahuricae, 5 parts of Radix Et Rhizoma Rhei, 30 parts of Caulis Loniceraes, 10 parts of Radix Paeoniae Rubra, 10 parts of Caulis Akebiaes, 10 parts of Radix Angelicae Sinensis, 10 parts of Scorpio, 10 parts of Zaocyss, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Cyperi (processed).
Using method of the present invention is: the calamitas urinae hominis in the external application group, Crinis Carbonisatus and Folium Hibisci Mutabilis are crushed to more than 100 orders, spread on the affected part after being in harmonious proportion with Oleum sesami; The all the components that will take orally simultaneously in the group is crushed to the 60-80 order, make behind the capsule oral, every capsules 0.5 gram left and right sides content; Also can add adjuvant and make pill.
Adopt the present invention to cure the disease for the herpes zoster patient, instant effect and evident in efficacy, effective percentage are high again; But just pain relieving in general 1-2 days, skin lesion begin to take a turn for the better, and all symptoms disappear substantially within 7 days, and effective percentage is 100%.In addition, all medical materials are conventional Chinese crude drug, not only have no side effect, and the medicine source are wide, and are cheap, and economic security is fit to general public fully and bears.
The specific embodiment
The Chinese medicine of treatment herpes zoster provided by the invention comprises external application group and group for oral administration;
Raw material in the external application group is formed and weight portion is: calamitas urinae hominis 25-35 part, and Crinis Carbonisatus 25-35 part, Folium Hibisci Mutabilis 52-68 part, Oleum sesami is an amount of;
Raw material in the group for oral administration forms and weight portion is: Radix Sophorae Flavescentis 25-35 part, Semen Coicis 25-35 part, Poria 16-24 part, Radix Angelicae Dahuricae 8-12 part, Radix Et Rhizoma Rhei 4-6, Caulis Lonicerae 25-35 part, Radix Paeoniae Rubra 8-12 part, Caulis Akebiae 8-12 part, Radix Angelicae Sinensis 8-12 part, Scorpio 8-12 part, Zaocys 8-12 part, Radix Bupleuri 8-12 part, Rhizoma Cyperi (processed) 8-12 part.
As preferably, the raw material in the external application group is formed and weight portion is: 30 parts of calamitas urinae hominises, and 30 parts of Crinis Carbonisatus, 60 parts of Folium Hibisci Mutabiliss, Oleum sesami is an amount of; Raw material in the group for oral administration forms and weight portion is: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Semen Coiciss, 20 parts in Poria, 10 parts of the Radixs Angelicae Dahuricae, 5 parts of Radix Et Rhizoma Rhei, 30 parts of Caulis Loniceraes, 10 parts of Radix Paeoniae Rubra, 10 parts of Caulis Akebiaes, 10 parts of Radix Angelicae Sinensis, 10 parts of Scorpio, 10 parts of Zaocyss, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Cyperi (processed).
Above-described Rhizoma Cyperi (processed) can be nine Rhizoma Cyperi (processed) balls, or nutagrass flatsedge rhizome bolus by seven processes, or four Rhizoma Cyperi (processed) balls, perhaps other Rhizoma Cyperi (processed) ball.
The whole buyables of above-described all raw materials.
Using method of the present invention is: the calamitas urinae hominis in the external application group, Crinis Carbonisatus and Folium Hibisci Mutabilis are crushed to more than 100 orders, spread on the affected part after being in harmonious proportion with Oleum sesami; The all the components that will take orally simultaneously in the group is crushed to the 60-80 order, make behind the capsule oral, about every capsules 0.5 gram.General oral consumption is every day 3 times, each 6, and one after each meal.Every patient is to external application group medicine one bag (20 gram), 126 of group capsules for oral administration.
In the prescription provided by the invention, Radix Sophorae Flavescentis, Semen Coicis, Poria, the Radix Angelicae Dahuricae, Radix Et Rhizoma Rhei, Caulis Lonicerae have dispel the wind, effect that heat clearing and damp drying is separated pyretic toxicity; Radix Paeoniae Rubra, Caulis Akebiae, Radix Angelicae Sinensis have blood stasis expelling to end logical, pathogenic fire purging diversion, the logical feeling pulse energy of enriching blood; Scorpio, Zaocys remove rheumatism, logical enrich blood arteries and veins, pain relieving; , Radix Bupleuri, Rhizoma Cyperi (processed) have the effect of reconciling superficies and interior, QI invigorating resolving depression.
Adopt the present invention that 106 patients are treated, the patient more than 80% obtained basic controlling in 1-3 days, can obtain rehabilitation in the week; January, the patient with severe symptoms of above medical history must be many with a course of treatment (7 days); Effective percentage is 100%, and none routine sequela takes place.In addition, early treatment medication early curative effect is better.
Model case is introduced:
1, Fuyang City's high bridge town, the flat 30 years old Zhejiang Province of man of Xuan Ze
On May 18th, 2004 came with regard to rash.Ill week more than one of readme, pain unbearably, and because of betiding the back so can not sleep peacefully.Fuyang hospital join Western medicine take invalid.Carry out external application and for oral administration with the present invention, second day promptly pain separate, skin lesion begins to take a turn for the better, week recovery from illness.
2, the San Kou of Linan City town, Li Xiang good fortune 45 years old Zhejiang Province of man
On July 25th, 2006 came with regard to rash.Ill January is surplus, and surperficial skin lesion is recovered as yet, and surplus leading to do not stopped focus breast abdominal part.Carry out external application and for oral administration, convalesce in 7 days with the present invention.
3, Fuyang City's civil administration village, blue precious younger sister 65 years old Zhejiang Province of woman
On August 12nd, 2005 came with regard to rash.Ill February is surplus, and skin lesion is not received, and pain is heavy, the focus chest.With external application of the present invention and for oral administration, pain disappeared in 3 days, took medicine in 10 days to recover.
Claims (2)
1. a Chinese medicine for the treatment of herpes zoster comprises external application group and group for oral administration;
Raw material in the external application group is formed and weight portion is: calamitas urinae hominis 25-35 part, and Crinis Carbonisatus 25-35 part, Folium Hibisci Mutabilis 52-68 part, Oleum sesami is an amount of;
Raw material in the group for oral administration forms and weight portion is: Radix Sophorae Flavescentis 25-35 part, Semen Coicis 25-35 part, Poria 16-24 part, Radix Angelicae Dahuricae 8-12 part, Radix Et Rhizoma Rhei 4-6, Caulis Lonicerae 25-35 part, Radix Paeoniae Rubra 8-12 part, Caulis Akebiae 8-12 part, Radix Angelicae Sinensis 8-12 part, Scorpio 8-12 part, Zaocys 8-12 part, Radix Bupleuri 8-12 part, Rhizoma Cyperi (processed) 8-12 part.
2. a kind of Chinese medicine for the treatment of herpes zoster according to claim 1 is characterized in that raw material composition and the weight portion in the described external application group is: 30 parts of calamitas urinae hominises, and 30 parts of Crinis Carbonisatus, 60 parts of Folium Hibisci Mutabiliss, Oleum sesami is an amount of;
Raw material in described for oral administration group is formed and weight portion is: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Semen Coiciss, 20 parts in Poria, 10 parts of the Radixs Angelicae Dahuricae, 5 parts of Radix Et Rhizoma Rhei, 30 parts of Caulis Loniceraes, 10 parts of Radix Paeoniae Rubra, 10 parts of Caulis Akebiaes, 10 parts of Radix Angelicae Sinensis, 10 parts of Scorpio, 10 parts of Zaocyss, 10 parts of Radix Bupleuri, 10 parts of Rhizoma Cyperi (processed).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710071381A CN101129425B (en) | 2007-09-21 | 2007-09-21 | Traditional Chinese medicine for treating zoster |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710071381A CN101129425B (en) | 2007-09-21 | 2007-09-21 | Traditional Chinese medicine for treating zoster |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101129425A true CN101129425A (en) | 2008-02-27 |
CN101129425B CN101129425B (en) | 2010-05-26 |
Family
ID=39126935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710071381A Expired - Fee Related CN101129425B (en) | 2007-09-21 | 2007-09-21 | Traditional Chinese medicine for treating zoster |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101129425B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488864A (en) * | 2011-12-09 | 2012-06-13 | 郑丽霞 | Medicinal composition for treating herpes zoster |
CN105343618A (en) * | 2015-12-02 | 2016-02-24 | 韩祎迪 | Traditional Chinese medicine preparation for fast treating herpes zoster |
CN105362721A (en) * | 2015-12-02 | 2016-03-02 | 卢雨萍 | Traditional Chinese medicine composition for treating herpes zoster |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1242773C (en) * | 2004-05-18 | 2006-02-22 | 郭冰洁 | Medicine for treating skin wound and its processing method |
CN100336525C (en) * | 2005-04-06 | 2007-09-12 | 广东嘉应制药股份有限公司 | Medicinal composition |
-
2007
- 2007-09-21 CN CN200710071381A patent/CN101129425B/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102488864A (en) * | 2011-12-09 | 2012-06-13 | 郑丽霞 | Medicinal composition for treating herpes zoster |
CN102488864B (en) * | 2011-12-09 | 2013-05-01 | 郑丽霞 | Medicinal composition for treating herpes zoster |
CN105343618A (en) * | 2015-12-02 | 2016-02-24 | 韩祎迪 | Traditional Chinese medicine preparation for fast treating herpes zoster |
CN105362721A (en) * | 2015-12-02 | 2016-03-02 | 卢雨萍 | Traditional Chinese medicine composition for treating herpes zoster |
Also Published As
Publication number | Publication date |
---|---|
CN101129425B (en) | 2010-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102309644B (en) | Traditional Chinese medical composition for treating bone fracture | |
CN100548350C (en) | A kind of Chinese medicine for the treatment of thromboangiitis obliterans | |
CN100506274C (en) | Traditional Chinese medicine for treating cervical vertebra disease | |
CN102228485B (en) | Composition for burn rehabilitation and preparation method thereof | |
CN102319327A (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
CN102319332B (en) | Musk bone reunion Chinese medicinal composition | |
CN101129425B (en) | Traditional Chinese medicine for treating zoster | |
CN112915173A (en) | Traditional Chinese medicine composition for treating orthopedic diseases, preparation method and application | |
CN100459999C (en) | Medicine for treating rheumatism | |
CN1843421A (en) | Rheumatoid disease treating medicine | |
CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
CN103055069B (en) | External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition | |
CN102698214B (en) | Traditional Chinese medicine for treating migraine and preparation method thereof | |
CN1160091C (en) | Medicine for treating ophthalmopathy | |
CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
CN103239625A (en) | Traditional Chinese medicinal preparation for treating facial paralysis | |
CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
CN105079206A (en) | Pain relieving traditional Chinese medicine composition and preparation method thereof | |
CN111358915A (en) | Traditional Chinese medicine for treating congenital muscular torticollis and preparation method thereof | |
CN104523861A (en) | Traditional Chinese medicine combination used for treating stroke and preparation method thereof | |
CN103893606B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN104288604B (en) | A kind of Chinese medicine composition for treating cerebral infarction | |
CN112755134B (en) | Plaster for treating hyperosteogeny and preparation method thereof | |
CN107753896A (en) | A kind of saussurea involucrata Wind-dispelling ointment and preparation method thereof | |
CN107468787A (en) | A kind of medicine-filled pillow of protect liver hypotensive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100526 Termination date: 20120921 |